Shingo Ashida

1.8k total citations
55 papers, 1.2k citations indexed

About

Shingo Ashida is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Shingo Ashida has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Shingo Ashida's work include Cancer, Hypoxia, and Metabolism (11 papers), Prostate Cancer Treatment and Research (10 papers) and Renal cell carcinoma treatment (7 papers). Shingo Ashida is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Prostate Cancer Treatment and Research (10 papers) and Renal cell carcinoma treatment (7 papers). Shingo Ashida collaborates with scholars based in Japan, United States and Netherlands. Shingo Ashida's co-authors include Taro Shuin, Mutsuo Furihata, Kenji Tamura, Tomoaki Fujioka, Hidewaki Nakagawa, Tsuneharu Miki, Toyomasa Katagiri, Yusuke Nakamura, Keiji Inoue and Ichiro Yamasaki and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Shingo Ashida

48 papers receiving 1.2k citations

Peers

Shingo Ashida
Ramaswamy Ramchandran United States
Giuseppe Fedele United States
Kristine Pelton United States
Catherine L. Cioffi United States
Rachel Bikoff United States
Ramaswamy Ramchandran United States
Shingo Ashida
Citations per year, relative to Shingo Ashida Shingo Ashida (= 1×) peers Ramaswamy Ramchandran

Countries citing papers authored by Shingo Ashida

Since Specialization
Citations

This map shows the geographic impact of Shingo Ashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Ashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Ashida more than expected).

Fields of papers citing papers by Shingo Ashida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Ashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Ashida. The network helps show where Shingo Ashida may publish in the future.

Co-authorship network of co-authors of Shingo Ashida

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Ashida. A scholar is included among the top collaborators of Shingo Ashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Ashida. Shingo Ashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shimasaki, Shunichi, Erika Yamashita, Hideo Fukuhara, et al.. (2025). Efficacy of preventive techniques against postoperative inguinal hernia in patients who underwent robot-assisted radical prostatectomy for Japanese patients. Journal of Robotic Surgery. 19(1). 730–730.
3.
Ashida, Shingo, Hideo Fukuhara, Nobutaka Shimizu, et al.. (2024). Comprehensive genomic profiling of primary bladder mucinous adenocarcinoma, a rare genitourinary cancer: A case report. Urology Case Reports. 58. 102892–102892.
4.
5.
Tamura, Kenji, Nobutaka Shimizu, Hideo Fukuhara, et al.. (2023). Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. Research and Reports in Urology. Volume 15. 157–164. 2 indexed citations
6.
Tamura, Kenji, Chiaki Kawada, Kazuhiro Maejima, et al.. (2023). Variant spectrum of von Hippel–Lindau disease and its genomic heterogeneity in Japan. Human Molecular Genetics. 32(12). 2046–2054. 6 indexed citations
7.
Tamura, Kenji, et al.. (2021). Well-differentiated liposarcoma of the spermatic cord: A case report. Urology Case Reports. 36. 101587–101587. 6 indexed citations
8.
Ashida, Shingo, Mohammed S. Orloff, Gürkan Bebek, et al.. (2012). Integrated Analysis Reveals Critical Genomic Regions in Prostate Tumor Microenvironment Associated with Clinicopathologic Phenotypes. Clinical Cancer Research. 18(6). 1578–1587. 34 indexed citations
9.
Tamura, Kenji, Mutsuo Furihata, Hirofumi Satake, et al.. (2011). SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression. Oncology Letters. 3(2). 264–268. 20 indexed citations
10.
Inoue, Keiji, Takashi Karashima, Tatsuo Iiyama, et al.. (2010). Pathobiological Influence of a Radiofrequency Ablation System. Pathobiology. 77(2). 64–77. 1 indexed citations
11.
Tamura, Kenji, Asami Makino, Françoise Hullin‐Matsuda, et al.. (2009). Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism. Cancer Research. 69(20). 8133–8140. 156 indexed citations
12.
Tamura, Kenji, Keiji Inoue, Shingo Ashida, et al.. (2009). [Localized Fournier's gangrene of the penis: a case report].. PubMed. 55(3). 153–6. 5 indexed citations
13.
Tamura, Kenji, Mutsuo Furihata, Motohide Uemura, et al.. (2009). Stanniocalcin 2 overexpression in castration‐resistant prostate cancer and aggressive prostate cancer. Cancer Science. 100(5). 914–919. 47 indexed citations
14.
Yamasaki, Ichiro, Isao Nishimori, Shingo Ashida, et al.. (2006). Clinical Characteristics of Pancreatic Neuroendocrine Tumors in Japanese Patients With von Hippel-Lindau Disease. Pancreas. 33(4). 382–385. 23 indexed citations
15.
Katagiri, Toyomasa, Shingo Ashida, Tomoaki Fujioka, et al.. (2005). Hypoxia-Inducible Protein 2 ( HIG2 ), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy. Cancer Research. 65(11). 4817–4826. 82 indexed citations
16.
Miyata, Yasuyoshi, Shingo Ashida, Takao Nakamura, et al.. (2003). Overexpression of hepatocyte growth factor receptor in renal carcinoma cells indirectly stimulates tumor growth in vivo. Biochemical and Biophysical Research Communications. 302(4). 892–897. 10 indexed citations
17.
Shuin, Taro, et al.. (2002). [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].. PubMed. 29(10). 1719–25. 1 indexed citations
18.
Yoshida, Minoru, Shingo Ashida, Keiichi Kondo, et al.. (2000). Germ‐line Mutation Analysis in Patients with von Hippel‐Lindau Disease in Japan: An Extended Study of 77 Families. Japanese Journal of Cancer Research. 91(2). 204–212. 47 indexed citations
19.
Kuroda, Naoto, Keishi Naruse, Eriko Miyazaki, et al.. (2000). Vinculin: Its Possible Use as a Marker of Normal Collecting Ducts and Renal Neoplasms with Collecting Duct System Phenotype. Modern Pathology. 13(10). 1109–1114. 28 indexed citations
20.
Ashida, Shingo, et al.. (1999). Nephrogenic adenoma of the bladder in a chronic hemodialysis patient. International Journal of Urology. 6(4). 208–210. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026